Fertifa, a London-based startup, helping European businesses to provide fertility and reproductive health benefits to employees has recently raised £5M in funding from Notion Capital and Triple Point Ventures. The round also saw participation from Conviction, Calm/Storm, Tiny.vc, EQT Foundation and a host of angel investors, along with the return of existing investors.
Launched in 2019 by Tony Chen and Nick Kuan, who have since exited the operational roles but remain shareholders, the startup currently employs 22 individuals. Eileen Burbidge, who joined as executive director in 2022 after leading the company’s pre-seed round along with her Passion Capital Partner Malin Posern, is steering the business.
She shares with TechCrunch: “As someone who grew up in America and now lives in the UK, I’m intensely sensitive to what appears to be a slow erosion or roll back of reproductive health rights (or even simply access to via public healthcare due to strains on the NHS and providers)—and I’m desperately keen to play a part in ensuring that as many people as possible have access to education and information so they may make the best choices for themselves.”
Fertifa’s services encompass fertility preservation, fertility planning, IVF, IUI and ICSI treatment cycles, contraception, surrogacy and adoption, and care for menopause, endometriosis, PCOS, fibroids, STIs, and men’s sexual health.
A key hurdle for Fertifa is the lack of action by some employers. To combat this, the company emphasizes the business case for providing reproductive health and wellbeing support and often finds a route in through employee networks or executive sponsors. Fertifa works with companies of all sizes, earning revenue through a per employee per month pricing model and a 5% fee on reimbursement administration.
The recent funding will enable Fertifa to launch new services such as treatment financing and expand its enterprise sales. The startup aims to establish itself as the market leader in the U.K. within a year, and lead the EMEA category by the end of 2024.
